C. O’Carroll

Acadia Pharmaceuticals (United States) — United States

Neuroscience · Life Sciences

10h-index3.3kcitations30works4.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Neuroscience and Neuropharmacology Research(12), Cannabis and Cannabinoid Research(12), Memory and Neural Mechanisms(4), Epilepsy research and treatment(3), Infant Development and Preterm Care(3)

Publications30 total

Discovery of VU6052254: A Novel, Potent M <sub>1</sub> Positive Allosteric Modulator
ACS Chemical Neuroscience·2025Open Access
Migraine And The Limbic System: Closing The Circle
Psychopharmacology Bulletin·2025· 10 cited
Application of Deuterium in an M<sub>1</sub> Positive Allosteric Modulator Back-Up Program: The Discovery of VU6045422
ACS Chemical Neuroscience·2025· 2 citedOpen Access
PPARδ AGONIST REN001 IMPROVES MITOCHONDRIAL FUNCTION IN SKELETAL MUSCLE: A POTENTIAL TREATMENT FOR PRIMARY MITOCHONDRIAL MYOPATHIES
Molecular Genetics and Metabolism·2023
PPARδ Agonism Ameliorates Renal Fibrosis in an Alport Syndrome Mouse Model
Kidney360·2022· 6 citedOpen Access
Increasing adult hippocampal neurogenesis is sufficient to improve pattern separation
Nature·2011· 1.5k cited
MODULATION OF AUDITORY AND VISUAL PROCESSING BY DELTA-9-TETRAHYDROCANNABINOL AND CANNABIDIOL: AN FMRI STUDY
Schizophrenia Research·2010· 12 cited
Effect of image analysis software on neurofunctional activation during processing of emotional human faces
Journal of Clinical Neuroscience·2010· 27 cited
Modulation of Mediotemporal and Ventrostriatal Function in Humans by Δ9-Tetrahydrocannabinol
Archives of General Psychiatry·2009· 245 citedOpen Access
P.3.02 Opposite neural effects of the main psychoactive ingredients of cannabis —implications for therapeutics
European Neuropsychopharmacology·2009· 1 cited
Neurofunctional Effects of Cannabis on Response Inhibition
European Psychiatry·2009· 1 citedOpen Access
P.1.e.020 Effects of cannabis ingredients in the temporal cortex – neural basis for potential antipsychotic effect of cannabidiol
European Neuropsychopharmacology·2008
Neural Basis of Δ-9-Tetrahydrocannabinol and Cannabidiol: Effects During Response Inhibition
Biological Psychiatry·2008· 187 cited
DELTA-9-TETRAHYDROCANNABINOL MODULATES MEDIAL TEMP AND STRIATAL FUNCTION IN HUMANS: A NEURAL BASIS FOR THE EFFECTS OF CANNABIS ON MEMORY AND PSYCHOSIS
Schizophrenia Research·2008
Delta-9-tetrahydrocannabinol modulates parahippocampal and ventral striatal activity during processing of verbal memory
European Psychiatry·2008
P.3.21 Delta-9-tetrahydrocannabinol modulates activity in parahippocampal cortex and ventral striatum during memory processing
European Neuropsychopharmacology·2008
Neural correlates of memory impairment and induction of psychotic symptoms by cannabis
2008
CBD and the neural correlates of anxiety
Program and Abstracts·2007
P.1.e.008 Delta-9-tetrahydrocannabinol modulates activity in temporal cortex during processing of verbal episodic memory
European Neuropsychopharmacology·2007· 2 cited
CBD and the neural correlates of anxiety
European Psychiatry·2007
page 1 of 2Next →

Frequent Co-authors

Philip McGuire(19), Zerrin Atakan(16), Sagnik Bhattacharyya(15), Paolo Fusar‐Poli(15), Stefan Borgwardt(14), Marc L. Seal(13), Rocı́o Martı́n-Santos(12), Paul Allen(8), J.A.S. Crippa(6), Chiara Nosarti(5), Richard Morris(4), R Martin-Santos(4), Stephen J. Martin(3), Katya Rubia(3), J.A. Crippa(3), Larry Rifkin(3), Robin Murray(3), Johan Sandin(2), José A. Crippa(2), Valter Fraccaro(2)